Filing Details
- Accession Number:
- 0001062993-19-002432
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-28 19:10:42
- Reporting Period:
- 2019-05-24
- Accepted Time:
- 2019-05-28 19:10:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1405235 | N Mark Wegman | C/O Biospecifics Technolgies Corp. 35 Wilbur Street Lynbrook NY 11563 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Disposition | 2019-05-24 | 7,800 | $61.09 | 65,272 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The selling price of $61.09 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $60.83 to $61.80. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.